Results 271 to 280 of about 32,390 (296)

Cardiac Remodeling and Functional Alterations in Heart Failure With Preserved Ejection Fraction (HFpEF): An Echocardiographic Assessment at a Tertiary Hospital in Bangladesh. [PDF]

Cureus
Rahman MW, Mahmood M, Adhikary DK, Ahmed CM, Hoque MH, Parvin T, Krishna Banerjee S, Khaled MFI.   +7 more
europepmc   +1 more source

Reply to the letter regarding the article ‘Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo‐controlled, crossover trial’

European Journal of Heart Failure, EarlyView.
Soufiane Nassiri, Geert H.D. Voordes, M. Louis Handoko, Adriaan A. Voors   +3 more
wiley   +1 more source

Short‐ and mid‐term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

European Journal of Heart Failure, EarlyView.
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi, Dennis Kannenkeril, Julie Kolwelter, Peter Linz, Agnes Bosch, Kristina Striepe, Marina V. Karg, Armin M. Nagel, Michael Uder, Mario Schiffer, Stephan Achenbach, Roland E. Schmieder   +11 more
wiley   +1 more source

Evaluating the Impact of Catheter Ablation on Cardiovascular and Cerebral Outcomes in Atrial Fibrillation With Heart Failure and Preserved Ejection Fraction. [PDF]

Clin Cardiol
Lee WC, Hsu WH, Lai CC, Chang WT, Liao CT, Shih JY, Chen ZC, Fang HY, Chen MC.   +8 more
europepmc   +1 more source

Investigating the Role of the Right Ventricle in Hfpef Using Exercise CMR

Roshan Xavier, Sher May Ng, Jiliu Pan, Jack J. Miller, Ferenc Mózes, Ladislav Valkovič, Jenny Rayner, Marzia Rigolli, Matthew Fronheiser, Stefan Neubauer, Andrew Lewis, Oliver J. Rider   +11 more
openalex   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus   +14 more
wiley   +1 more source

Haemodynamic-guided and device-free shunting for heart failure with preserved ejection fraction. [PDF]

Heart
Reddy YNV, Miranda WR.
europepmc   +1 more source

Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RA has expanded therapeutic options for this population. This expert consensus
Luca Monzo, Gianluigi Savarese, Wilfried Mullens, Amr Abdin, Biykem Bozkurt, Ovidiu Chioncel, Seif El Hadidi, Thomas M. Gorter, Riccardo M. Inciardi, Mark C. Petrie, Gabriele G. Schiattarella, Davide Stolfo, Marco Metra, Nicolas Girerd   +13 more
wiley   +1 more source

Glucagon-like peptide-1 receptor agonists and obesity paradox in heart failure with preserved ejection fraction: a systematic review. [PDF]

Cardiovasc Endocrinol Metab
Hullon D, Janiec K, Florova V, Trach A, Volkova Y, Mnevets R.   +5 more
europepmc   +1 more source

Finerenone in patients with severe heart failure: The FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
Severe heart failure and treatment with finerenone. CI, confidence interval; CV, cardiovascular; HF, heart failure; LVEF, left ventricular ejection fraction; RR, rate ratio. Aims While patients with severe heart failure (HF) were historically considered to have reduced left ventricular ejection fraction (LVEF), it is increasingly recognized that severe
Riccardo M. Inciardi, Henri Lu, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D. Henderson, Carolyn S.P. Lam, Bela Merkely, Michael Zi Miao, Michele Senni, Sanjiv J. Shah, Kavita Sharma, Orly Vardeny, Mark C. Petrie, Subodh Verma, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Flaviana Amarante, James Lay‐Flurrie, Andrea Glasauer, Andrea Scalise, John J.V. McMurray, Muthiah Vaduganathan, Scott D. Solomon   +24 more
wiley   +1 more source